Stockreport

ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action

EOM PHARMACEUTICAL HLDNGS  (IMUC) 
NASDAQ:AMEX Investor Relations: investors.imuc.com
PDF LOS ANGELES, Aug. 09, 2019 (GLOBE NEWSWIRE) -- ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (OTC: IMUC), today issued the following announcement. The followin [Read more]